420 related articles for article (PubMed ID: 12894197)
21. Drug screening--beyond the bottleneck.
Dove A
Nat Biotechnol; 1999 Sep; 17(9):859-63. PubMed ID: 10471925
[TBL] [Abstract][Full Text] [Related]
22. Ready for an orange revolution in biotechnology?
Thuret JY; Blondel M
Biotechnol J; 2006 Mar; 1(3):237-8. PubMed ID: 16897701
[No Abstract] [Full Text] [Related]
23. Synthetic library design.
Huwe CM
Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
[TBL] [Abstract][Full Text] [Related]
24. Introduction: cell-based assays for high-throughput screening.
An WF; Tolliday NJ
Methods Mol Biol; 2009; 486():1-12. PubMed ID: 19347612
[TBL] [Abstract][Full Text] [Related]
25. Functional assays for screening GPCR targets.
Thomsen W; Frazer J; Unett D
Curr Opin Biotechnol; 2005 Dec; 16(6):655-65. PubMed ID: 16257523
[TBL] [Abstract][Full Text] [Related]
26. Use of high-content analysis for compound screening and target selection.
Rausch O
IDrugs; 2005 Jul; 8(7):573-7. PubMed ID: 15973566
[TBL] [Abstract][Full Text] [Related]
27. Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models.
Kloss D; Kurz R; Jahnke HG; Fischer M; Rothermel A; Anderegg U; Simon JC; Robitzki AA
Biosens Bioelectron; 2008 May; 23(10):1473-80. PubMed ID: 18289841
[TBL] [Abstract][Full Text] [Related]
28. Image-based screening: a technology in transition.
Ramm P
Curr Opin Biotechnol; 2005 Feb; 16(1):41-8. PubMed ID: 15722014
[TBL] [Abstract][Full Text] [Related]
29. Hit and Lead identification: efficient practices for drug discovery.
Goodnow RA; Gillespie P
Prog Med Chem; 2007; 45():1-61. PubMed ID: 17280901
[No Abstract] [Full Text] [Related]
30. Solid-phase compound library synthesis in drug design and development.
Edwards PJ; Morrell AI
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):594-605. PubMed ID: 12197317
[TBL] [Abstract][Full Text] [Related]
31. Embryonic stem cells as a novel cell source of cell-based biosensors.
Liu Q; Huang H; Cai H; Xu Y; Li Y; Li R; Wang P
Biosens Bioelectron; 2007 Jan; 22(6):810-5. PubMed ID: 16621504
[TBL] [Abstract][Full Text] [Related]
32. Applications of self-organizing neural networks in virtual screening and diversity selection.
Selzer P; Ertl P
J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
[TBL] [Abstract][Full Text] [Related]
33. Application of combinatorial chemistry science on modern drug discovery.
Kennedy JP; Williams L; Bridges TM; Daniels RN; Weaver D; Lindsley CW
J Comb Chem; 2008; 10(3):345-54. PubMed ID: 18220367
[No Abstract] [Full Text] [Related]
34. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
35. "Spirit" of high throughput screening.
Wesche H; Xiao SH; Young S
Comb Chem High Throughput Screen; 2008 Mar; 11(3):174. PubMed ID: 18336210
[No Abstract] [Full Text] [Related]
36. Preclinical drug discovery research and training at Vanderbilt.
Lindsley CW; Weaver D; Jones C; Marnett L; Conn PJ
ACS Chem Biol; 2007 Jan; 2(1):17-20. PubMed ID: 17243778
[No Abstract] [Full Text] [Related]
37. Advances in high-throughput high-performance liquid chromatography and "purification-friendly" combinatorial library design strategies.
Schefzick S
Adv Chromatogr; 2007; 45():197-213. PubMed ID: 17626560
[No Abstract] [Full Text] [Related]
38. Process optimization using combinatorial design principles: parallel synthesis and design of experiment methods.
Gooding OW
Curr Opin Chem Biol; 2004 Jun; 8(3):297-304. PubMed ID: 15183328
[TBL] [Abstract][Full Text] [Related]
39. The synergy between combinatorial chemistry and high-throughput screening.
Diller DJ
Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
[TBL] [Abstract][Full Text] [Related]
40. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
